h-VIOS
Systemic Bio Closes, but Founder Taci Pereira’s Mission Continues
Systemic Bio, the 3D Systems subsidiary working to transform drug development with bioprinted tissue models, has officially closed. The news came in an emotional, personal, and powerful blog post by…
Systemic Bio Opens Bioprinting Lab to Accelerate Drug Discovery
3D Systems (NYSE: DDD) spinoff Systemic Bio opened a state-of-the-art laboratory to conduct research into hydrogel scaffold manufacturing and organ-on-a-chip as part of its mission to accelerate drug discovery and…
Featured
3D Systems Spins off Bioprinting Startup Systemic Bio
After venturing deeply into the bioprinting space, 3D Systems (NYSE: DDD) is shifting gears by spinning out its assets in this sector into a new, wholly owned company: Systemic Bio….
